Browsing by Author "79a1106c-1b79-4eb2-960a-ac8fbfb33aa5"
Now showing items 1-5 of 5
-
Guevara Oliva, Carlos; Villa, Eduardo; Díaz Tapia, Violeta; Garrido Inostroza, Cristian; Martínez, Melissa; Orellana, Patricia; Alarcón Arias, Pablo; Silva Rosas, Carlos; Barker, Gareth J.; Kempton, Matthew J.; Grazia, José de (Elsevier, 2020)Background: : In relapsing -remitting multiple sclerosis (RRMS), no evidence of disease activity -3 (NEDA-3) is defined as the absence of: (1) relapses; (2) disability progression; (3) MRI activity (new/enlarged T2 lesions ...
-
Guevara Oliva, Carlos; Farías Gontupil, Gonzalo; Bulatova, Kateryna; Alarcón Arias, Pablo; Soruco Pastrana, Wendy; Robles Morales, Carlos; Morales, Marcelo (Frontiers, 2017-06-09)Dissections of extracranial arteries are estimated to account for only 2% of all ischemic strokes but for approximately 20% of strokes in patients younger than 45 years old. Most dissections of extracranial arteries involve ...
-
Guevara Oliva, Carlos; Villa, Eduardo; Silva Rosas, Carlos; Díaz Tapia, Violeta; Naves Pichuante, Rodrigo Antonio (Elsevier, 2020)
-
Guevara Oliva, Carlos; Bulatova, Katherina; Barker, Gareth J.; González, Guido; Crossley, Nicolás A.; Kempton, Matthew J. (Frontiers Media, 2016)Background: The absence of markers for ante-mortem diagnosis of progressive supranuclear palsy (PSP), results in this disorder being commonly mistaken for other conditions, such as idiopathic Parkinson's disease (IPD). ...
-
Guevara Oliva, Carlos; Bulatova, K.; Barker, G. J.; González, G.; Crossley, N.; Kempton, M. J. (Hindawi, 2016)In multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), the absence of surrogate endpoints makes clinical trials long and expensive. We aim to determine annualized whole-brain atrophy rates (a-WBAR) in ...